Hemangioma Thrombocytopenia SyndromeSymptoms, Doctors, Treatments, Advances & More
Learn About Hemangioma Thrombocytopenia Syndrome
- Hemangioma thrombocytopenia syndrome
- KMP
- Kasabach Merritt phenomenon
- Kasabach Merritt syndrome
- Thrombocytopenia-hemangioma syndrome
Ballad Health Cancer Center
Asheesh Shipstone is a Hematologist and an Oncologist practicing medicine in Kingsport, Tennessee. Dr. Shipstone is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia. Dr. Shipstone is board certified in American Board Of Internal Medicine.
Abingdon Physician Partners - Regional Cancer Center At Johnston Memorial Hospital
Timothy Davis is an Internal Medicine provider practicing medicine in Abingdon, Virginia. Dr. Davis is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Familial Colorectal Cancer, Thrombocytopenia, and Colorectal Cancer. Dr. Davis is board certified in American Board Of Internal Medicine.
Advocate Infusion Center
Mohammed Raheem is a Hematologist and an Oncologist practicing medicine in Aurora, Illinois. Dr. Raheem is rated as a Distinguished provider by MediFind in the treatment of Hemangioma Thrombocytopenia Syndrome. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Raheem is board certified in American Board Of Internal Medicine, Medical Oncology.
Summary: This randomized clinical trial evaluates if low-dose sirolimus (target trough 4-8 ng/mL) combined with prednisolone is noninferior in efficacy but superior in safety compared to standard high-dose sirolimus (target trough 10-15 ng/mL) combined with prednisolone in pediatric patients with kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon (KHE with KMP), with participants randomized 1:...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center